-
Radio Frequency Renal Ablation Device and Disposable Reticular Renal Denervation RF Ablation Catheter Approved for Marketing
2025-02-19
Recently, the two innovative products "Radio Frequency Renal Ablation Device" and "Disposable Reticular Renal Denervation RF Ablation Catheter" of Shanghai Golden Leaf Med Tec Co., Ltd. are approved by China NMPA.
-
Balloon Cryoablation Catheter Approved for Marketing
2025-02-19
Recently, the innovative product "Cryoablation Console" of Shanghai Antec Medical Technology Co., Ltd. is approved by China NMPA.
-
Prizvalve® Transcatheter Aortic Valve System Approved for Marketing
2025-02-19
Recently, the innovative product "Prizvalve® Transcatheter Aortic Valve System" of Shanghai NewMed Medical Co., Ltd. is approved by China NMPA.
-
Vflower® Venous Stent System Approved for Marketing
2025-02-19
Recently, the innovative product "Vflower® Venous Stent System" of Shanghai Bluevastec MedTech Co., Ltd. is approved by China NMPA.
-
NMPA Announcement on Including the Testing Methods for Azelaic Acid and Its Salts in Cosmetics and Other 5 Testing Methods into the Technical Specification for the Safety of Cosmetics (Edition 2015) (No. 45, 2024)
2025-02-19
The National Medical Products Administration (NMPA) has organized to formulate Testing Methods for Azelaic Acid and Its Salts in Cosmetics and other 5 testing methods, which have been reviewed and approved by the Chairman's Meeting of the NMPA's Cosmetic Standardization Technical Committee.
-
NMPA Re-elected as a Member of the ICH Management Committee
2025-02-19
On June 4, 2024, the plenary session of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) was held in Fukuoka, Japan, at which the National Medical Products Administration (NMPA) was elected as a member of the ICH Management Committee for the third time.
